title: Drug approvals: '08 in review. Nebivolol (Bystolic).
authors.affiliation: Oregon Health and Science University, Portland, Ore., USA.
authors.forename: Gary
authors.initials: G
authors.lastname: Laustsen
authors.forename: Fernando
authors.initials: F
authors.lastname: Carrillo
authors.forename: Jessica
authors.initials: J
authors.lastname: Johnson
authors.forename: Cynthia
authors.initials: C
authors.lastname: Smith
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D001578:Benzopyrans / Q000494:pharmacology / Q000627:therapeutic use*; D004983:Ethanolamines / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D000068577:Nebivolol
chemical_list: D000319:Adrenergic beta-Antagonists; D001578:Benzopyrans; D004983:Ethanolamines; D000068577:Nebivolol